Content
- National Cardiovascular Laboratory
- The Future Health Competence Centre at Semmelweis University
- Development of an AI-based drug discovery platform: microRNA therapy for cardiometabolic and oncology diseases
- MicroRNA therapy development for cardiometabolic and oncological diseases
- Translational research and innovation in the diagnosis and treatment of ischemic heart disease and its comorbidities
- Molecular Mechanisms of Cardiological and Onco-Cardiological Diseases: Diagnostic and Therapeutic Investigations
- The Role of Inflammatory Mechanisms in Heart Failure and Cardiac Dysfunction Associated with Non-Alcoholic Steatohepatitis (NASH)
- The Effect of Metabolic Diseases on Extracellular Vesicle-Based Signaling in the Cardiovascular System
- Hidden cardiotoxicity and cardioprotection in translational cell culture models
- New inflammatory mechanisms in the development of heart failure
- Endothelial cell and ER-mitochondria signalling in myocardial infarction-associated microvascular obstruction
- Analysis of bacterial and bile acid abnormalities in the small intestine caused by non-steroidal anti-inflammatory drugs and the effect of cannabinoids on enteropathy
- Exploring the role of the glycinergic system in the development of opioid analgesic tolerance